SCHEMBL791413

SCHEMBL791413

Clc1ccc2nocc2c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.44
RAB9A P51151 1/20 0.44
PIK3CG P48736 2/20 0.41
F7 P08709 1/20 0.39
F3 P13726 1/20 0.39
DYRK1A Q13627 1/20 0.39
CYP2A6 P11509 1/20 0.38
PSMB8 P28062 1/20 0.38
PSMB5 P28074 1/20 0.38
ALDH1A1 P00352 4/20 0.37
MAPT P10636 2/20 0.37
LMNA P02545 1/20 0.37
CYP1A2 P05177 1/20 0.37
THRB P10828 1/20 0.37
ALOX15 P16050 1/20 0.37
MAPK1 P28482 1/20 0.37
HTR3E A5X5Y0 1/20 0.37
HTR3B O95264 1/20 0.37
HTR3A P46098 1/20 0.37
BACE1 P56817 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28707763 0.83 NR4A2 (0.44) PIK3CGF7F3DYRK1ACYP2A6
SCHEMBL28538700 0.74 BACE1 (0.44) NPC1RAB9ACYP2A6ALDH1A1MAPT
SCHEMBL2491067 0.74 PLAU (0.47) NPC1RAB9ADYRK1AALDH1A1MAPT
SCHEMBL2491479 0.69 NPC1 (0.51) NPC1RAB9ADYRK1AALDH1A1CYP1A2
SCHEMBL2493204 0.69 RAB9A (0.55) NPC1RAB9ACYP2A6ALDH1A1MAPT
SCHEMBL23913875 0.69 SCN10A (0.44) NPC1RAB9AALDH1A1MAPTLMNA
SCHEMBL2494247 0.69 APP (0.48) NPC1RAB9APSMB5ALDH1A1MAPT
SCHEMBL405106 0.69 ALDH1A1 (0.41) NPC1RAB9APIK3CGALDH1A1MAPT
SCHEMBL6647893 0.68 TDP1 (0.49) NPC1RAB9AALDH1A1MAPTLMNA
SCHEMBL21672373 0.67 NPC1 (0.39) NPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119431439-A Method for preparing 2-formylaryl (phosphinic) phosphine/phosphoramide compound 岳阳凯茂化工材料有限公司 2025-02-14 CN claimed
CN-113214178-B 3-aryl substituted anthranilic anhydride derivative and preparation method thereof 广东工业大学 2022-05-13 CN claimed
CN-113214178-A 3-aryl substituted anthranilic anhydride derivative and preparation method thereof 广东工业大学 2021-08-06 CN claimed
CN-119431439-A Method for preparing 2-formylaryl (phosphinic) phosphine/phosphoramide compound 岳阳凯茂化工材料有限公司 2025-02-14 CN disclosed
CN-113214178-B 3-aryl substituted anthranilic anhydride derivative and preparation method thereof 广东工业大学 2022-05-13 CN disclosed
CN-109912503-B Synthetic method of 2, 3-diacyl quinoline compound 江南大学 2022-04-08 CN disclosed
CN-110204487-B Synthesis method of quinoline derivative 江南大学 2021-09-28 CN disclosed
CN-113214178-A 3-aryl substituted anthranilic anhydride derivative and preparation method thereof 广东工业大学 2021-08-06 CN disclosed
CN-109776488-B Synthesis method of alpha-ketoamide compound with ortho-aldehyde group 江南大学 2021-04-27 CN disclosed
EP-3233844-A1 3-(6-ALKOXY-5-CHLOROBENZO[D]ISOXAZOL-3-YL)PROPANOIC ACID USEFUL AS KYNURENINE MONOOXYGENASE INHIBITORS GlaxoSmithKline Intellectual Property Development Limited (GB) 2017-10-25 EP disclosed
WO-2016097144-A1 3-(6-ALKOXY-5-CHLOROBENZO[D]ISOXAZOL-3-YL)PROPANOIC ACID USEFUL AS KYNURENINE MONOOXYGENASE INHIBITORS GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2016-06-23 WO disclosed
WO-2012037108-A1 AMINOQUINOLINE DERIVATIVES AS ANTIVIRAL AGENTS GLAXOSMITHKLINE LLC (US) 2012-03-22 WO disclosed
WO-2012037108-A1 AMINOQUINOLINE DERIVATIVES AS ANTIVIRAL AGENTS GLAXOSMITHKLINE LLC (US) 2012-03-22 WO disclosed
EP-0741702-A4 PROCESS FOR PREPARING 2-OXINDOLE-1-CARBOXAMIDES CATALYTICA INC (US) 1997-12-03 EP disclosed
EP-0741702-A1 PROCESS FOR PREPARING 2-OXINDOLE-1-CARBOXAMIDES CATALYTICA, INC. (US) 1996-11-13 EP disclosed
WO-1995020574-A1 PROCESS FOR PREPARING 2-OXINDOLE-1-CARBOXAMIDES CATALYTICA, INC. (US) 1995-08-03 WO disclosed
CN-1071917-A Quinazoline derivant as human immunodeficiency virus reversed transcriptive enzyme antagonist MERCK & CO INC (US) 1993-05-12 CN disclosed